These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31019193)

  • 1. In vivo rendezvous of small nucleic acid drugs with charge-matched block catiomers to target cancers.
    Watanabe S; Hayashi K; Toh K; Kim HJ; Liu X; Chaya H; Fukushima S; Katsushima K; Kondo Y; Uchida S; Ogura S; Nomoto T; Takemoto H; Cabral H; Kinoh H; Tanaka HY; Kano MR; Matsumoto Y; Fukuhara H; Uchida S; Nangaku M; Osada K; Nishiyama N; Miyata K; Kataoka K
    Nat Commun; 2019 Apr; 10(1):1894. PubMed ID: 31019193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
    Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
    Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural tuning of oligonucleotides for enhanced blood circulation properties of unit polyion complexes prepared from two-branched poly(ethylene glycol)-block-poly(l-lysine).
    Naito M; Chaya H; Toh K; Kim BS; Hayashi K; Fukushima S; Nagata T; Yokota T; Kataoka K; Miyata K
    J Control Release; 2021 Feb; 330():812-820. PubMed ID: 33417983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer.
    Gibori H; Eliyahu S; Krivitsky A; Ben-Shushan D; Epshtein Y; Tiram G; Blau R; Ofek P; Lee JS; Ruppin E; Landsman L; Barshack I; Golan T; Merquiol E; Blum G; Satchi-Fainaro R
    Nat Commun; 2018 Jan; 9(1):16. PubMed ID: 29295989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phenylboronate-functionalized polyion complex micelle for ATP-triggered release of siRNA.
    Naito M; Ishii T; Matsumoto A; Miyata K; Miyahara Y; Kataoka K
    Angew Chem Int Ed Engl; 2012 Oct; 51(43):10751-5. PubMed ID: 22907668
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanoparticles mimicking viral surface topography for enhanced cellular delivery.
    Niu Y; Yu M; Hartono SB; Yang J; Xu H; Zhang H; Zhang J; Zou J; Dexter A; Gu W; Yu C
    Adv Mater; 2013 Nov; 25(43):6233-7. PubMed ID: 23946251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuned Density of Anti-Tissue Factor Antibody Fragment onto siRNA-Loaded Polyion Complex Micelles for Optimizing Targetability into Pancreatic Cancer Cells.
    Min HS; Kim HJ; Ahn J; Naito M; Hayashi K; Toh K; Kim BS; Matsumura Y; Kwon IC; Miyata K; Kataoka K
    Biomacromolecules; 2018 Jun; 19(6):2320-2329. PubMed ID: 29767505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles.
    Kim HJ; Takemoto H; Yi Y; Zheng M; Maeda Y; Chaya H; Hayashi K; Mi P; Pittella F; Christie RJ; Toh K; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
    ACS Nano; 2014 Sep; 8(9):8979-91. PubMed ID: 25133608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
    Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
    Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14-specific chimeric siRNA/nanocarrier complex.
    Taniguchi H; Natori Y; Miyagi Y; Hayashi K; Nagamura F; Kataoka K; Imai K
    Int J Cancer; 2021 Aug; 149(3):646-656. PubMed ID: 33783816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
    Yi Y; Kim HJ; Zheng M; Mi P; Naito M; Kim BS; Min HS; Hayashi K; Perche F; Toh K; Liu X; Mochida Y; Kinoh H; Cabral H; Miyata K; Kataoka K
    J Control Release; 2019 Feb; 295():268-277. PubMed ID: 30639386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.
    Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
    Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform.
    Morry J; Ngamcherdtrakul W; Gu S; Reda M; Castro DJ; Sangvanich T; Gray JW; Yantasee W
    Mol Cancer Ther; 2017 Apr; 16(4):763-772. PubMed ID: 28138033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes.
    Shi Y; Jiang Y; Cao J; Yang W; Zhang J; Meng F; Zhong Z
    J Control Release; 2018 Dec; 292():163-171. PubMed ID: 30408555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic poly(α)glutamate polymeric micelles for systemic administration of siRNA to tumors.
    Krivitsky A; Polyak D; Scomparin A; Eliyahu S; Ofek P; Tiram G; Kalinski H; Avkin-Nachum S; Feiner Gracia N; Albertazzi L; Satchi-Fainaro R
    Nanomedicine; 2018 Feb; 14(2):303-315. PubMed ID: 29127036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
    Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of RNA Strand Rigidity on Polyion Complex Formation with Block Catiomers.
    Hayashi K; Chaya H; Fukushima S; Watanabe S; Takemoto H; Osada K; Nishiyama N; Miyata K; Kataoka K
    Macromol Rapid Commun; 2016 Mar; 37(6):486-93. PubMed ID: 26765970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAse A-like enzymes in serum inhibit the anti-neoplastic activity of siRNA targeting polo-like kinase 1.
    Haupenthal J; Baehr C; Zeuzem S; Piiper A
    Int J Cancer; 2007 Jul; 121(1):206-10. PubMed ID: 17351902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1.
    Xu L; Zhu Y; Shao J; Chen M; Yan H; Li G; Zhu Y; Xu Z; Yang B; Luo P; He Q
    Br J Cancer; 2017 Apr; 116(8):1027-1036. PubMed ID: 28267710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
    J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.